Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sleep Disorders in Patients With Multiple Sclerosis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2005 by Groupe Hospitalier Pitie-Salpetriere.
Recruitment status was  Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Information provided by:
Groupe Hospitalier Pitie-Salpetriere Identifier:
First received: August 29, 2005
Last updated: February 8, 2006
Last verified: August 2005
Fatigue is a frequent and disabling symptom in patients with multiple sclerosis (MS). The pathophysiology of this sign is not fully understood. Some data suggest that the fatigue is associated with sleep disorders. The aim of this study is to determine the polysomnographic parameters in MS patients with fatigue in comparison to MS patients without fatigue.

Multiple Sclerosis

Study Type: Observational
Study Design: Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Study of Sleep Disorders and Fatigue in Patients With Multiple Sclerosis

Resource links provided by NLM:

Further study details as provided by Groupe Hospitalier Pitie-Salpetriere:

Estimated Enrollment: 51

Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with multiple sclerosis
  • Expanded Disability Status Scale score < or = 5
  • Fatigue (Modified Fatigue Impact Scale > 45), with a disease duration > 3 months

Exclusion Criteria:

  • Depression
  • Cognitive disorders
  • EDSS > 5
  • Epilepsia
  • Obesity
  • Drug inducing sleep disorders
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00137904

Contact: Bruno Stankoff, MD, PhD 33-142161950

Centre d'Investigation Clinique-Hopital Pitié-Salpêtrière Recruiting
Paris, France, 75013
Contact: Marie-Laure Welter, MD    33-42161950   
Principal Investigator: Bruno Stankoff, MD, PhD         
Sponsors and Collaborators
Groupe Hospitalier Pitie-Salpetriere
Institut National de la Santé Et de la Recherche Médicale, France
Principal Investigator: Bruno Stankoff, MD, PhD CIC-Pitié-Salpêtrière
  More Information Identifier: NCT00137904     History of Changes
Other Study ID Numbers: RBM0242 
Study First Received: August 29, 2005
Last Updated: February 8, 2006
Health Authority: France: Ministry of Health

Keywords provided by Groupe Hospitalier Pitie-Salpetriere:
multiple sclerosis
sleep disorders

Additional relevant MeSH terms:
Multiple Sclerosis
Sleep Wake Disorders
Pathologic Processes
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases
Neurologic Manifestations
Signs and Symptoms
Mental Disorders processed this record on October 21, 2016